Clinical Trial Update: CART-19 Immunotherapy in Mantle Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a CART-19 immunotherapy being evaluated in Phase 1/2 for Mantle Cell Lymphoma, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• CART-19 Immunotherapy (CAR-T cells targeting CD19)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Hematopoietic/Lymphoid Cancer, Non-hodgkin Lymphoma,B Cell | Phase 1, Phase 2 | Status: UNKNOWN